collaboration
Oxford Nanopore, Dubai Health Partner on Carrier Screening Using Nanopore Sequencing
The collaborators aim to demonstrate the capabilities of nanopore sequencing in samples with known mutations and in a prospective study to identify disease carriers.
Shimadzu, Singapore's DxD Hub Partner on Diagnostic Development Center
The center aims to accelerate the development of high-quality, cost-effective diagnostic products for infectious diseases, cancer, and metabolic disorders.
CityUHK, Cellomics to Develop Circulating Tumor Cell Screening Platform
Within two years, the team hopes to commercialize an assay that combines cell sorting, staining, and imaging, as well as protein and gene profiling.
Tethis, Sheba Medical Center Trying to Predict Rectal Cancer Relapse Earlier With CTCs, ctDNA
Sheba researchers will use Tethis' technology to prepare patients' blood samples for circulating tumor cells and circulating tumor DNA analysis.
Cure51, French Hospital Network Partner to Study Biomarkers of Survival in Pancreatic Cancer
Cure51 and Assistance Publique – Hôpitaux de Paris have partnered to identify biomarkers for long-term survival in pancreatic cancer.